Molecular Pharmacology - Radioligand binding Flashcards

1
Q

what is question 1 of the exam going to be on

A

quantitative analysis
it is compulsory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the rationale behind resolving specific receptor binding

A

receptor binding is finite and saturable
non-specific binding is non-saturable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do you calculate specific binding

A

measure the non-specific non-saturable binding then measure the difference between that and the total binding
gives us the specific saturable binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the criterion for designing a radioligand binding assay

A

1 - decide on the receptor source
2 - identify appropriate radioligands
3 - identify means to separate bound and unbound ligands
4 - identify means to distinguish specific and non-specific binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does a radioligand binding assay allow us to do

A

develop an estimate of ligand bound at different concentrations of ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the criteria for identifying an appropriate ligand

A

1 - high affinity to receptor
2 - slow dissociation kinetics
3 - prefer an antagonist over agonist - doesn’t cause changes in receptor structure
4 - high selectivity - specific
5 - compatible with labelling techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what isotopes do we usually use for radioligand binding assays

A

tritium
carbon-14
phosphorous-32
sulphur-35
iodine-131

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the becquerel (Bq)

A

Bq = number of disintegrations per second
usually per minute (d.p.m)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how do we link the Bq back to a concentration of a ligand

A

we use the Curie constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the Curie (Ci) constant

A

2.22 x 10^23 d.p.m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do we link the Ci d.p.m to the concentration of ligand

A

we need to know its specific activity (SA)
SA = activity/mol
e.g. - 20Ci/mmol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do we measure radioactivity in solution

A

Scintillation counting - converts radioactivity into emitted light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the different ways to separate bound from unbound ligand

A

filtration
sedimentation
centrifugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is equilibrium dialysis used to

A

if you are working with soluble receptors
you have 2 chambers separated by a semi-permeable membrane
allows free ligand to diffuse across leaving behind bound ligand and receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how is competition binding used to distinguish specific vs non-specific binding

A

we keep our radioligand of known affinity constant
increase concentration of unlabelled competitor (cold ligand/analogue)
to displace the non-specific binding of the radioligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is IC50

A

the concentration of cold ligand that displaces 50% of the radioligand specific binding

17
Q

what information can we derive from a competition binding derived IC50 curve

A

affinity of a specific receptor to ligand (Kd)
pharmacological profile of the receptor
number of receptor sites in a tissue (Bmax)
characteristics of the drug-receptor interaction

18
Q

what is occupation theory and what assumption does this allow us to make

A

that the number of receptors occupied is proportional to the response
EC50 = Kd

19
Q

what is the problem with occupation theory

A

it is not true
does not need all the receptors to produce maximal response

20
Q

what are the disadvantages of radioligand binding

A

cannot distinguish between agonist/antagonist/partial agonists
non-physiological environment
long incubation times - may lead to receptor desensitisation

21
Q

what are the advantages of radioligand binding assays

A

no pharmacokinetic confounds
direct measure of Kd
direct measure of Bmax
defines molecular characteristics of drug-receptor interaction
suitable for high throughput screening
defines pharmacological profile of receptor

22
Q

you need to redo lecture 3

A

how well do you understand it

23
Q

what are the advantages of a direct plot

A

does not require data transformation
requires no modelling
no distortion of data points

24
Q

what is 90%/95%/99% of the Bmax equal to in terms of Kd

A

90% of Bmax = 9 x Kd
95% 0f Bmax = 19 x Kd
99% of Bmax = 99 x Kd

25
Q

what does a curved scatchard plot indicate

A

that there is more than one binding site - site heterogeneity

26
Q

what will you need to be able to do for the exam

A

a scatchard plot
no hill plot - only tell what information it gives

27
Q

what is the IC50 dependent on

A

the concentration of radiolabelled ligand used and its Kd

28
Q

how do we convert the IC50 into an affinity constant

A

the Cheng-Prusoff equation corrects and calculates the equilibrium dissociation constant for the inhibitor

29
Q
A